Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma
Clinical trial NCT04850846 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04850846
- Sponsor
- Dana-Farber Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-27
- Primary completion
- 2025-01-29
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.